CLASS II Device recall · Reported 16 May 2018 · FDA Enforcement Report

Zymutest HIA MonoStrip IgG recalled by Hyphen BioMed

Hyphen BioMed is recalling Zymutest HIA MonoStrip IgG, distributed in Maryland, North Carolina, New Hampshire, New York, Ohio. The recall was initiated on 5 Feb 2018 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot numbers: F1701084P2 and F1701084P3

Quantity recalled12

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number: Z-1742-2018
FDA event ID: 79797
Recalling firm: Hyphen BioMed, Neuville Sur Oise, N/A
Classification: Class II
Status: Terminated
Recall initiated: 5 Feb 2018
FDA classified: 8 May 2018
Reported: 16 May 2018
Type: Voluntary: Firm initiated
Customers notified by: E-Mail
Reason category: Packaging Defects
Device type: Test Kits & Diagnostics

Timeline

5 Feb 2018	Recall initiated by company
8 May 2018	Classified by FDA	+92 days
16 May 2018	Published in enforcement report	+8 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Incorrect package insert indicating use of the kits with plasma, serum, and other biological fluids. The kits should only be used with plasma.

Packaging recalls include wrong labels, wrong products in the wrong bottle, missing leaflets, short-filled or empty capsules and seals that fail.

Product as listed by the FDA

ZYMUTEST HIA MonoStrip IgG; REF Number: RK041A; UDI: 03663537046803 a qualitative assay intended for the detection of heparin-dependent antibodies of the IgG isotype, in human plasma, by clinical laboratories. It is intended for in vitro diagnostic use.

Where it was distributed

OH, MD, NC, NY, NH, Canada, Sweden

Maryland North Carolina New Hampshire New York Ohio

Questions about this recall

Why was it recalled?

Incorrect package insert indicating use of the kits with plasma, serum, and other biological fluids. The kits should only be used with plasma.

Which lots are affected?

Lot numbers: F1701084P2 and F1701084P3

Where was it sold?

OH, MD, NC, NY, NH, Canada, Sweden

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

Other products in this recall event

2 other products · FDA event 79797

This product is part of a recall event; the main page for the event is Zymutest HIA MonoStria qualitative screening assay intended recalled.

Reported	Class	Recall	Company	Reason	Where
16 May 2018	CLASS II	Zymutest HIA MonoStria qualitative screening assay intended recalled	Hyphen BioMed	Packaging Defects	5 states
16 May 2018	CLASS II	Zymutest HIA IgGAM recalled by Hyphen BioMed	Hyphen BioMed	Packaging Defects	5 states

More recalls from Hyphen BioMed

All 5

Reported	Class	Recall	Company	Reason	Where
16 May 2018Device	CLASS II	Zymutest HIA IgGAM recalled by Hyphen BioMed	Hyphen BioMed	Packaging Defects	5 states
16 May 2018Device	CLASS II	Zymutest HIA MonoStria qualitative screening assay intended recalled	Hyphen BioMed	Packaging Defects	5 states
21 Mar 2018Device	CLASS II	Zymutest HIA MonoStrip IgGAM recalled by Hyphen BioMed	Hyphen BioMed	Potency & Assay
21 Mar 2018Device	CLASS II	Zymutest HIA IgGAM recalled by Hyphen BioMed	Hyphen BioMed	Potency & Assay

Other Test Kits & Diagnostics recalls

All 2,656

Reported	Class	Recall	Company	Reason	Where
9 Sep 2026Device	CLASS II	STA Staclot Protein recalled by Diagnostica Stago	Diagnostica Stago	Potency & Assay	Nationwide
26 Aug 2026Device	CLASS II	DxC 500i Clinical Analyzer Modules using recalled by Beckman Coulter	Beckman Coulter	Packaging Defects	Nationwide
26 Aug 2026Device	CLASS II	DxC 500 AU Clinical Analyzer Modules using recalled by Beckman Coulter	Beckman Coulter	Packaging Defects	Nationwide
26 Aug 2026Device	CLASS II	Syva EMIT 2000 Quinidine Assay recalled	Siemens Healthcare Diagnostics	Potency & Assay	Nationwide
26 Aug 2026Device	CLASS II	Beckman Coulter, Emit 2000 Quinidine Assay recalled	Siemens Healthcare Diagnostics	Potency & Assay	Nationwide